listing by a Chinese firm on record, after Alibaba Group Holding Ltd.’s $25 billion blockbuster debut in 2014. HONG KONG (July 8): Chinese medical data group LinkDoc Technology Ltd has shelved plans for an IPO in the United States following Beijings clampdown on overseas listings by domestic firms, according to three sources with direct knowledge of the matter. this year, according to data compiled by Bloomberg. Its investors include Alibaba Health Information Technology Ltd., MBK Partners, New Enterprise Associates and Temasek Holdings Pte according to a preliminary filing.Ĭhinese companies have raised about $13 billion through first-time share sales in the U.S. LinkDoc, founded in 2014, provides cancer focused health-care services built on big data and artificial intelligence, its website shows. A representative for LinkDoc declined to comment. The retail quota is 35, QIB is 50, and HNI is 15. ![]() crores via IPO that comprises fresh issue of 766 crores and offer for sale up to 3,369,360 equity shares of 10 each. Reuters reported LinkDoc’s IPO halt earlier Thursday. Syrma SGS Technology IPO date is fixed yet, the IPO is to open on August 12 and will close on August 18, 2022. LinkDoc’s IPO delay also comes as regulators in Beijing are planning rule changes that would allow them to block a Chinese company from listing overseas even if the unit selling shares is incorporated outside China, closing a loophole long-used by the country’s technology giants, Bloomberg News reported this week. plunged after the government ordered the removal of the ride-hailing giant’s app from local app stores within days of its $4.4 billion U.S. ![]() Company had estimated IPO funds, combined with current cash and cash flow. Chinese technology stocks suffered a rout after China signaled a new era of tighter oversight over cybersecurity. LinkDoc has indefinitely shelved its 211 million IPO, with no word on when or if it will eventually proceed.
0 Comments
Leave a Reply. |